Hydroxychloroquine use in COVID-19: is the risk of cardiovascular toxicity justified?

The outbreak of COVID-19 in Wuhan, China and its declaration as a global pandemic by WHO has left the medical community under significant pressure to rapidly identify effective therapeutic and preventative strategies. Chloroquine (CQ) and its analogue hydroxychloroquine (HCQ) were found to be effica...

Descripción completa

Detalles Bibliográficos
Autores principales: Stevenson, Alex, Kirresh, Ali, Conway, Samuel, White, Laura, Ahmad, Mahmood, Little, Callum
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Special Populations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7440188/
https://www.ncbi.nlm.nih.gov/pubmed/32817375
http://dx.doi.org/10.1136/openhrt-2020-001362

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7440188/
https://www.ncbi.nlm.nih.gov/pubmed/32817375
http://dx.doi.org/10.1136/openhrt-2020-001362

Ejemplares similares